Related Experiment Video
Updated: Aug 30, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Solitary Rectal Ulcer Syndrome Is Not Always Ulcerated: A Case Report
Yi Liu1, Zhihao Chen1, Lizhou Dou1
1Department of Endoscopy, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Solitary rectal ulcer syndrome (SRUS) can mimic rectal cancer, leading to misdiagnosis. Early differentiation is crucial for appropriate treatment of this benign condition.
Area of Science:
- Gastroenterology
- Colorectal Surgery
- Pathology
Background:
- Solitary rectal ulcer syndrome (SRUS) is a chronic disorder with varied symptoms like rectal bleeding and straining.
- Its etiology is unclear, and diagnosis is often challenging due to overlapping symptoms with other conditions.
- SRUS can be misdiagnosed, complicating effective treatment strategies.
Observation:
- A case report details a 37-year-old male with a nonulcerated rectal lesion.
- The lesion's endoscopic and pathological appearance mimicked superficial rectal cancer.
- This case highlights diagnostic challenges in distinguishing SRUS from malignancy.
Findings:
- The presented case underscores the potential for SRUS to be misdiagnosed as rectal cancer.
- Endoscopic and pathological analysis is key to accurate differentiation.
- Prompt recognition is vital to avoid unnecessary aggressive treatments.
Implications:
- Accurate diagnosis of SRUS is essential to prevent misclassification as rectal cancer.
- Endoscopists must be aware of SRUS's varied presentations to avoid diagnostic errors.
- Distinguishing SRUS from superficial rectal cancer ensures appropriate patient management and outcomes.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

